Cesarean Section

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
Closure of uterine incision at C sectionN/A1 trial
Active Trials
NCT02288013Completed100Est. Dec 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Johnson & JohnsonClosure of uterine incision at C section

Clinical Trials (1)

Total enrollment: 100 patients across 1 trials

NCT02288013Johnson & JohnsonClosure of uterine incision at C section

Uterine Closure at C-section by Stratafix Tissue Control Device: Randomized Case-Control Study

Start: Oct 2013Est. completion: Dec 2014100 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space